ClassID:

20896

A61K38/06 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tripeptides

Recent Application in this class:
#301
20200360483
2020-11-19

METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE

#302
20200360462
2020-11-19

METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH

#303
20200354402
2020-11-12

PEPTIDE COMPOSITIONS AND RELATED METHODS

#304
20200353076
2020-11-12

Anti-folate receptor alpha antibody conjugated with hemiasterlins

#305
20200345804
2020-11-05

Agents targeting inhibitor of apoptosis proteins

#306
20200345803
2020-11-05

Methods and compositions for the prevention or treatment of Barth Syndrome

#307
20200338154
2020-10-29

Compositions and methods for invasive and non-invasive procedural skincare

#308
20200330417
2020-10-22

Amino acid compositions and methods for the treatment of liver diseases

#309
20200325206
2020-10-15

Peptides and combination of peptides for use in immunotherapy against various tumors

#310
20200325171
2020-10-15

Proteasome inhibitors

#311
20200323947
2020-10-15

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#312
20200323943
2020-10-15

MALIGNANT TUMOR TARGET PEPTIDE

#313
20200323894
2020-10-15

Combination formulation of three antiviral compounds

#314
20200308250
2020-10-01

Peptides and combination of peptides for use in immunotherapy against various tumors

#315
20200297660
2020-09-24

APPLICATIONS OF SPERMINE AND DERIVATIVES THEREOF

#316
20200289606
2020-09-17

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS

#317
20200289475
2020-09-17

Riluzole prodrugs and their use

#318
20200282005
2020-09-10

Adhesion prevention material

#319
20200282004
2020-09-10

Solid Pharmaceutical Compositions for Treating HCV

#320
20200282003
2020-09-10

MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY

#321
20200276263
2020-09-03

Treatments of oxidative stress conditions

#322
20200276260
2020-09-03

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

#323
20200271651
2020-08-27

Methods, compositions, and kits for detection of aspergillosis

#324
20200268829
2020-08-27

METHODS AND COMPOSITIONS FOR INHIBITING METASTASES OF AN ENDOTHELIN B RECEPTOR EXPRESSING CANCER

#325
20200261588
2020-08-20

Intermediate drug with synergistic anticancer activity and polyethylene glycol-coupled synergistic anticancer drug, and preparation method therefor and use thereof

#326
20200254050
2020-08-13

STABLE COMPOSITIONS OF NEUROACTIVE PEPTIDES

#327
20200237861
2020-07-30

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#328
20200237855
2020-07-30

TREATMENT OF PTSD

#329
20200237852
2020-07-30

Small Molecule Enhancers of Paneth Cell Function and Differentiation

#330
20200231626
2020-07-23

Peptide inhibitors of tight junction permeability

#331
20200223887
2020-07-16

Aromatic-cationic peptides and methods for using same

#332
20200209237
2020-07-02

Detection and treatment of autoimmune disorders

#333
20200207865
2020-07-02

Cytotoxic and anti-mitotic compounds, and methods of using the same

#334
20200207809
2020-07-02

Tripeptide epoxy ketone protease inhibitors

#335
20200197472
2020-06-25

COSMETIC COMPOSITIONS

#336
20200190140
2020-06-18

Peptide compound, production method therefor, and use thereof

#337
20200172598
2020-06-04

METHODS FOR PURIFYING PROTEINS HAVING A TUBULIN CARBOXYPEPTIDASE ACTIVITY AND PEPTIDIC BASED INHIBITORS THEREOF

#338
20200171061
2020-06-04

Methods for Cancer Therapy

#339
20200155637
2020-05-21

PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE

#340
20200147229
2020-05-14

ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES

#341
20200121661
2020-04-23

Methods for the treatment of cancer metastasis

#342
20200113966
2020-04-16

METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION

#343
20200113965
2020-04-16

Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue

#344
20200113920
2020-04-16

COMPOSITIONS AND METHODS FOR TREATMENT OF MICROSPORIDIA INFECTION USING PROTEASOME INHIBITORS INCLUDING IXAZOMIB

#345
20200109167
2020-04-09

Small molecule DCN1 inhibitors and therapeutic methods using the same

#346
20200102565
2020-04-02

Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer

#347
20200093799
2020-03-26

Peptides for skin rejuvenation and methods of using the same

#348
20200087378
2020-03-19

Relaxin1 derived peptides for use in immunotherapy

#349
20200085906
2020-03-19

Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB

#350
20200085794
2020-03-19

Riluzole prodrugs and their use

#351
20200078437
2020-03-12

Immunoproteasome inhibitor

#352
20200071337
2020-03-05

ANTIVIRAL COMPOUNDS

#353
20200062803
2020-02-27

AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS

#354
20200061147
2020-02-27

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS

#355
20200046625
2020-02-13

COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES

#356
20200040060
2020-02-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#357
20200038325
2020-02-06

Liposomal compositions and methods of use

#358
20200031899
2020-01-30

Peptides and combination of peptides for use in immunotherapy against various tumors

#359
20200024325
2020-01-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#360
20200024309
2020-01-23

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#361
20200017911
2020-01-16

Methods and compositions for detecting and diagnosing diseases and conditions

#362
20200000869
2020-01-02

Augmenting the immune response by promoting cell death of immune cells

#363
20190388492
2019-12-26

METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY

#364
20190388376
2019-12-26

Compositions and methods for the treatment of hemoglobinopathies and thalassemias

#365
20190380952
2019-12-19

Immunostimulatory method

#366
20190375845
2019-12-12

METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND ENHANCING TUMOR VACCINES

#367
20190374596
2019-12-12

PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME

#368
20190365845
2019-12-05

METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE

#369
20190365748
2019-12-05

Inhibitors of hepatitis C virus

#370
20190358286
2019-11-28

METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING

#371
20190358144
2019-11-28

Compositions comprising peptide WKDEAGKPLVK

#372
20190350888
2019-11-21

COMPOSITION FOR THE TREATMENT OF VEISALGIA

#373
20190350224
2019-11-21

METHOD FOR IMPROVING MUSCLE FORCE OR PHYSICAL FUNCTION

#374
20190345254
2019-11-14

CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME

#375
20190343856
2019-11-14

Compositions for the treatment of skin conditions

#376
20190343851
2019-11-14

METHODS FOR CANCER THERAPY

#377
20190343807
2019-11-14

PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER

#378
20190336648
2019-11-07

Bone-promoting thermoresponsive macromolecules

#379
20190336566
2019-11-07

METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY

#380
20190336565
2019-11-07

Methods for Treating HCV

#381
20190321437
2019-10-24

Compositions and methods of use thereof to promote muscle growth and function

#382
20190314515
2019-10-17

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#383
20190314497
2019-10-17

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

#384
20190314444
2019-10-17

ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES

#385
20190314443
2019-10-17

Composition for suppressing muscular atrophy

#386
20190314442
2019-10-17

COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES

#387
20190309018
2019-10-10

Peptides useable for treating cancer

#388
20190300595
2019-10-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#389
20190300570
2019-10-03

Site-specific chemoenzymatic protein modifications

#390
20190298763
2019-10-03

USE OF DNA NETOSIS TO DELIVER TRAIL FOR CANCER THERAPY

#391
20190282601
2019-09-19

PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE

#392
20190276468
2019-09-12

Antiviral compounds

#393
20190275101
2019-09-12

Structure of GII.4 norovirus protease—design of broad-spectrum protease inhibitors

#394
20190269785
2019-09-05

Cytotoxic and anti-mitotic compounds, and methods of using the same

#395
20190269749
2019-09-05

METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE

#396
20190262418
2019-08-29

Compositions and methods for invasive and non-invasive procedural skincare

#397
20190248837
2019-08-15

Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer

#398
20190248833
2019-08-15

METHODS FOR REDUCING CD36 EXPRESSION

#399
20190240283
2019-08-08

Nutritional supplements containing a peptide component and uses thereof

#400
20190233472
2019-08-01

Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof

#401
20190224273
2019-07-25

Nutritional supplements containing a peptide component and uses thereof

#402
20190224270
2019-07-25

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS

#403
20190224269
2019-07-25

Inhibitors of IAP

#404
20190216882
2019-07-18

Solid Pharmaceutical Compositions for Treating HCV

#405
20190216881
2019-07-18

Compositions for preserving photoreceptor cells, retinal pigment epithelial cells, or visual function

#406
20190209641
2019-07-11

METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME

#407
20190209499
2019-07-11

Methods of treating or alleviating adenylosuccinatelyase (ADSL) deficiency using spermidine or a pharmaceutically acceptable salt of spermidine

#408
20190209493
2019-07-11

Applications of spermine and derivatives thereof

#409
20190209456
2019-07-11

Cosmetic compositions

#410
20190203210
2019-07-04

Increasing ATOH1 life to drive sensorineural hair cell differentiation

#411
20190202860
2019-07-04

Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient

#412
20190201556
2019-07-04

FLUOROCHEMICAL TARGETED THERAPIES

#413
20190185540
2019-06-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#414
20190175687
2019-06-13

Combination Therapy

#415
20190175684
2019-06-13

Malignant tumor target peptide

#416
20190142965
2019-05-16

Hydrogel for engineered immune response to D-chirality peptides

#417
20190142893
2019-05-16

Electron, Radical, or Reactive Oxygen Species-Scavenging Agent Based Therapy of Inborn Errors of Fatty Acid Oxidation and Oxidative Phosphorylation

#418
20190127359
2019-05-02

Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

#419
20190125773
2019-05-02

METHODS FOR CANCER THERAPY

#420
20190119352
2019-04-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#421
20190119351
2019-04-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#422
20190111014
2019-04-18

Dual ACE C-domain/NEP inhibitors

#423
20190105294
2019-04-11

Amino acid compositions and methods for the treatment of liver diseases

#424
20190099467
2019-04-04

Methods and compositions for preserving retinal ganglion cells

#425
20190091247
2019-03-28

Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs

#426
20190085023
2019-03-21

Crystal of reduced glutathione and method for producing same

#427
20190083640
2019-03-21

Polycomplexes of poly-lysine compounds for preventing and/or combatting amyotrophic lateral sclerosis

#428
20190076553
2019-03-14

METHODS AND ASSAYS FOR TREATING SUBJECTS WITH SHANK3 DELETION, MUTATION OR REDUCED EXPRESSION

#429
20190076538
2019-03-14

Cholecystokinin B receptor targeting for imaging and therapy

#430
20190076500
2019-03-14

COMBINATIONS COMPRISING FXR AGONISTS

#431
20190071466
2019-03-07

Crystal of reduced glutathione and method for producing same

#432
20190062371
2019-02-28

PEPTIDE COMPOSITIONS AND RELATED METHODS

#433
20190056386
2019-02-21

ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

#434
20190046600
2019-02-14

COMPOSITIONS AND USES THEREOF

#435
20190046486
2019-02-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURONAL INJURY

#436
20190030115
2019-01-31

Peptide analogues with branched amino acid probe(s)

#437
20190030114
2019-01-31

ISOFORM-SPECIFIC CALPAIN INHIBITORS, METHODS OF IDENTIFICATION, AND USES THEREOF

#438
20190023762
2019-01-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#439
20190015517
2019-01-17

Conjugates of quaternized tubulysin compounds

#440
20190008918
2019-01-10

IMMUNOMODULATION THERAPIES FOR CANCER

#441
20190008858
2019-01-10

Inhibitors of hepatitis C virus

#442
20190008737
2019-01-10

Tyrosinase inhibitors

#443
20190002524
2019-01-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#444
20180371014
2018-12-27

CHIRAL COMPOUNDS OF VARYING CONFORMATIONAL RIGIDITY AND METHODS OF SYNTHESIS

#445
20180369204
2018-12-27

Pharmaceutical combinations for treating cancer

#446
20180362579
2018-12-20

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#447
20180360906
2018-12-20

METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION

#448
20180360905
2018-12-20

Inhibitors for proliferating cell nuclear antigen and uses

#449
20180346548
2018-12-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#450
20180344814
2018-12-06

PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME

#451
20180344803
2018-12-06

Methods and Compositions For the Treatment of Proteinuric Diseases

#452
20180340019
2018-11-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#453
20180339060
2018-11-29

Bifunctional cytotoxic agents

#454
20180339016
2018-11-29

Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof

#455
20180327475
2018-11-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#456
20180327468
2018-11-15

Histatins and method of use thereof

#457
20180327450
2018-11-15

AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME

#458
20180327367
2018-11-15

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#459
20180311302
2018-11-01

CXCR antagonistic peptides and uses thereof

#460
20180311301
2018-11-01

MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY

#461
20180303902
2018-10-25

ENGINEERED INTEGRIN BINDING PEPTIDE COMPOSITIONS

#462
20180296637
2018-10-18

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#463
20180296516
2018-10-18

Amino acid compositions and methods for the treatment of liver diseases

#464
20180291099
2018-10-11

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

#465
20180291061
2018-10-11

Peptides of use in the preventive and curative treatment of alopecia

#466
20180289826
2018-10-11

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#467
20180289767
2018-10-11

Compositions and methods for invasive and non-invasive procedural skincare

#468
20180271991
2018-09-27

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#469
20180271902
2018-09-27

Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease

#470
20180271856
2018-09-27

METAP2 inhibitors and methods of treating obesity

#471
20180264131
2018-09-20

HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF

#472
20180264126
2018-09-20

Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting

#473
20180264072
2018-09-20

Polypeptides comprising vinculin binding sites for the treatment of proliferation and/or adhesion related diseases

#474
20180258155
2018-09-13

RELAXIN1 derived peptides for use in immunotherapy against various tumors

#475
20180256737
2018-09-13

Conjugates for treating diseases caused by PSMA expressing cells

#476
20180256736
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#477
20180256735
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#478
20180256734
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#479
20180256733
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#480
20180256724
2018-09-13

Hydrogels for delivery of therapeutic compounds

#481
20180251517
2018-09-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#482
20180250253
2018-09-06

Glycine for use in tolerance induction in allergic patients

#483
20180244683
2018-08-30

ANTIVIRAL COMPOUNDS

#484
20180237493
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#485
20180236112
2018-08-23

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

#486
20180230194
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

#487
20180221436
2018-08-09

Treatments of oxidative stress conditions

#488
20180214448
2018-08-02

Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

#489
20180208667
2018-07-26

Cytotoxic and anti-mitotic compounds, and methods of using the same

#490
20180208641
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#491
20180208640
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#492
20180207119
2018-07-26

AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE DISEASES AND DISORDERS

#493
20180207118
2018-07-26

Amino acid compositions and methods for the treatment of liver diseases

#494
20180193494
2018-07-12

Compound and pharmaceutical composition for tumor imaging and tumor therapy

#495
20180193473
2018-07-12

Compositions and methods for the treatment of platinum-drug resistant cancer

#496
20180193405
2018-07-12

Methods and compositions for the prevention and treatment of disease

#497
20180186833
2018-07-05

Selective cysteine protease inhibitors and uses thereof

#498
20180186806
2018-07-05

ANTIVIRAL COMPOUNDS

#499
20180185435
2018-07-05

METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE

#500
20180177845
2018-06-28

Method for treatment or prevention of a cancer

#501
20180177838
2018-06-28

CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE

#502
20180171034
2018-06-21

Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof

#503
20180169178
2018-06-21

Augmenting the immune response by promoting cell death of immune cells

#504
20180169045
2018-06-21

Amino acid compositions and methods for the treatment of liver diseases

#505
20180161279
2018-06-14

GASTRO-RETENTIVE MODIFIED RELEASE DOSAGE FORMS FOR OPROZOMIB AND PROCESS TO MAKE THEREOF

#506
20180155322
2018-06-07

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

#507
20180147291
2018-05-31

Prodrugs of peptide epoxy ketone protease inhibitors

#508
20180147251
2018-05-31

Methods and compositions for the prevention or treatment of Barth Syndrome

#509
20180141993
2018-05-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#510
20180134750
2018-05-17

Inhibition of gliadin peptides

#511
20180133281
2018-05-17

NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING

#512
20180125778
2018-05-10

Topical Compositions And Methods For Stimulating MIR-146A In Skin Cells

#513
20180117112
2018-05-03

METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE

#514
20180110865
2018-04-26

Polymer systems and their applications in diagnostics and drug delivery

#515
20180110823
2018-04-26

ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES

#516
20180104304
2018-04-19

METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME

#517
20180104303
2018-04-19

Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase

#518
20180100005
2018-04-12

Peptides and combination of peptides for use in immunotherapy against various tumors

#519
20180085478
2018-03-29

Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents

#520
20180079780
2018-03-22

Peptide compound, production method therefor, and use thereof

#521
20180071408
2018-03-15

Cholecystokinin 2 receptor targeted NIR imaging and use thereof

#522
20180066016
2018-03-08

Method of using pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor

#523
20180064816
2018-03-08

CROSSLINKED HYALURONIC ACID COMPOSITIONS

#524
20180055970
2018-03-01

Bioactive nanofiber cyto-scaffold

#525
20180049973
2018-02-22

Cosmetic Compostions

#526
20180044408
2018-02-15

Anti-ED-A immunoconjugates for inflammatory bowel disease

#527
20180042982
2018-02-15

Methods for Treating HCV

#528
20180037629
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#529
20180037626
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#530
20180036364
2018-02-08

METHODS OF TREATING CANCER WITH A PSMA LIGAND-TUBULYSIN COMPOUND

#531
20180030113
2018-02-01

Peptides and combination of peptides for use in immunotherapy against various tumors

#532
20180028681
2018-02-01

COMBINATION THERAPY USING A CD19-ADC AND VINCRISTINE

#533
20180021403
2018-01-25

Combinations of proteasome inhibitors and cyclic peptides

#534
20180002376
2018-01-04

ANTI-MICROBIAL PEPTIDES AND USES OF SAME

#535
20180000930
2018-01-04

Methods and Compositions for Preserving the Viability of Photoreceptor Cells

#536
20180000886
2018-01-04

Prevention and treatment of itch with an MRGPR antagonist

#537
20170368134
2017-12-28

PROTEASOME INHIBITORS FOR TREATING A DISORDER RELATED TO AN ACCUMULATION OF NON-DEGRADED ABNORMAL PROTEIN OR A CANCER

#538
20170360874
2017-12-21

Combination formulation of three antiviral compounds

#539
20170334853
2017-11-23

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

#540
20170333517
2017-11-23

Compositions and methods for inhibiting fibrosis

#541
20170326197
2017-11-16

Methods and compositions for preventing or treating ophthalmic conditions

#542
20170326135
2017-11-16

METAP2 inhibitors and methods of treating obesity

#543
20170319647
2017-11-09

Combination therapies using cyclosporine and aromatic cationic peptides

#544
20170314027
2017-11-02

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

#545
20170314023
2017-11-02

Matriptase inhibitors and uses thereof against orthomyxoviridae infections

#546
20170313760
2017-11-02

Peptides and combination of peptides for use in immunotherapy against various tumors

#547
20170305967
2017-10-26

METHODS FOR REDUCING CD36 EXPRESSION

#548
20170304408
2017-10-26

Metallic gold cluster molecules as therapeutic agents for arthritic animals

#549
20170304403
2017-10-26

METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE

#550
20170281716
2017-10-05

Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing

#551
20170281672
2017-10-05

Systems and methods for delivery of peptides

#552
20170275695
2017-09-28

Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease

#553
20170275334
2017-09-28

LINEAR PEPTIDE ANTIBIOTICS

#554
20170267718
2017-09-21

Tripeptide compound, preparation method therefor, and application thereof

#555
20170260230
2017-09-14

Compounds for enzyme inhibition

#556
20170258936
2017-09-14

Tunable pH-sensitive linker for controlled drug release

#557
20170258932
2017-09-14

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#558
20170258747
2017-09-14

GLUTAMINE ENRICHED NUTRITIONAL COMPOSITION FOR PRETERM INFANTS

#559
20170247408
2017-08-31

Cytotoxic and anti-mitotic compounds, and methods of using the same

#560
20170246312
2017-08-31

Immunostimulatory method

#561
20170246237
2017-08-31

Self-assembling tripeptides

#562
20170240592
2017-08-24

GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY

#563
20170232032
2017-08-17

Pharmaceutical compositions for treating ebola virus disease

#564
20170224760
2017-08-10

Compositions and methods for invasive and non-invasive procedural skincare

#565
20170224759
2017-08-10

Compositions and methods for treating colorectal cancer

#566
20170218021
2017-08-03

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#567
20170218018
2017-08-03

Cyclin based inhibitors of CDK2 and CDK4

#568
20170218014
2017-08-03

Azaindoline compounds as granzyme B inhibitors

#569
20170216393
2017-08-03

Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells

#570
20170209524
2017-07-27

Methods and compounds to suppress viral genome release and packaging

#571
20170202814
2017-07-20

Agents for the treatment of retroviral infectious diseases

#572
20170196933
2017-07-13

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#573
20170189468
2017-07-06

TISSUE REGENERATION PROMOTER

#574
20170189439
2017-07-06

Methods for treating HCV

#575
20170189382
2017-07-06

Compounds for treating brain cancer

#576
20170182117
2017-06-29

THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC SMALL MOLECULES AND USES THEREOF

#577
20170176459
2017-06-22

NEUROTOXICITY BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ACUTE TRAUMATIC BRAIN AND SPINAL CORD INJURY

#578
20170174722
2017-06-22

LLP2A-bisphosphonate conjugates for osteoporosis treatment

#579
20170152563
2017-06-01

Therapeutic agent for emphysema and COPD

#580
20170151238
2017-06-01

Methods for treating HCV

#581
20170145073
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#582
20170143784
2017-05-25

MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY

#583
20170136084
2017-05-18

INHIBITORS OF IAP

#584
20170128519
2017-05-11

CASPASE INHIBITORS FOR THE TREATMENT OF COLORECTAL CANCER

#585
20170121367
2017-05-04

Agonists of neurotrophin receptors and their use as medicaments

#586
20170114048
2017-04-27

Compounds and combinations for the treatment of HIV

#587
20170112748
2017-04-27

N-ACYLPEPTIDE DERIVATIVES AND THEIR USES

#588
20170101438
2017-04-13

COSMETIC OR PHARMACEUTICAL METHODS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR USING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS

#589
20170100448
2017-04-13

TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPASE INHIBITORS

#590
20170096451
2017-04-06

INHIBITION OF GLIADIN PEPTIDES

#591
20170088582
2017-03-30

Macrocyclic broad spectrum antibiotics

#592
20170087202
2017-03-30

Inflammation inhibiting compounds

#593
20170081361
2017-03-23

Hydroxystatin derivatives for the treatment of arthrosis

#594
20170071907
2017-03-16

Thieno-indole moieties and methods of treating using the same

#595
20170065669
2017-03-09

Antithrombotic nanoparticle

#596
20170065664
2017-03-09

Methods for the treatment of glaucoma and age-related macular degeneratiion by a peptide D-TRP-AIB

#597
20170049912
2017-02-23

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

#598
20170049844
2017-02-23

STABLE COMPOSITIONS OF NEUROACTIVE PEPTIDES

#599
20170049843
2017-02-23

Hepatocyte Growth Factor Mimics as Therapeutic Agents

#600
20170042969
2017-02-16

Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity